Tech Company M&A Transactions
Focal Therapeutics Acquisition
On 10/1/2018, Focal Therapeutics was purchased by Hologic. The parties disclosed the acquisition price to be $125 million.
Transaction Overview
Company Name
Acquired By
Announced On
10/1/2018
Transaction Type
M&A
Amount
$125,000,000
M&A Terms
Hologic announced today that it has signed a definitive agreement to acquire Focal Therapeutics, a privately-held company, for $125 million in cash. In conjunction with Hologic's recent acquisition of Faxitron Bioptics, Focal strengthens the Company's position in the rapidly growing market for breast conserving surgery.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
30 Enterprise 220
Aliso Viejo, CA 92656
USA
Aliso Viejo, CA 92656
USA
Phone
Website
Email Address
Overview
Focal Therapeutics is a medical device company that was established to help surgeons, radiation oncologists, and other clinicians to clearly identify a surgical site through the use of an innovative marker.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Gex
Chief Financial Officer
Steven Naber
Chief Medical Officer
Gail Lebovic
President
George Hermann
VP - Marketing
Brian Driscoll
VP - Sales
Dan Beney
Browse more venture capital transactions:
Prev: 9/29/2018: Blok.Party venture capital transaction
Next: 10/2/2018: Re:Store venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document tech company VC transactions. VC transactions on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs